- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/663 - Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
Patent holdings for IPC class A61K 31/663
Total number of patents in this class: 543
10-year publication summary
|
47
|
59
|
60
|
28
|
37
|
23
|
21
|
19
|
14
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 358 |
70 |
| The Regents of the University of California | 20506 |
26 |
| Abiogen Pharma S.p.A. | 154 |
13 |
| California Institute of Technology | 4011 |
8 |
| The University of North Carolina at Chapel Hill | 2069 |
7 |
| Novartis AG | 10350 |
6 |
| Centre National de La Recherche Scientifique | 10870 |
6 |
| Duke University | 3164 |
6 |
| Nitto Denko Corporation | 8466 |
5 |
| Daiichi Sankyo Company, Limited | 1885 |
5 |
| EirGen Pharma Limited | 88 |
5 |
| Inbiomotion S.L. | 19 |
5 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3339 |
5 |
| Ono Pharmaceutical Co., Ltd. | 421 |
5 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 24 |
4 |
| The Johns Hopkins University | 5813 |
4 |
| Tsinghua University | 6101 |
4 |
| Amorphical Ltd. | 65 |
4 |
| Innate Pharma | 157 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3125 |
4 |
| Other owners | 347 |